Siemens Healthineers and the Indian Institute of Science (IISc) inaugurated the Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory for AI in Precision Medicine at IISc Bangalore on Wednesday.
Peter Schardt, Chief Technology Officer of Siemens Healthineers, inaugurated this state-of-the-art laboratory. The CDS collaborative laboratory will develop open-source AI-based tools to precisely automate the segmentation of pathological findings in neuroimaging data, with a focus on accurately diagnosing neurological diseases and analyzing their clinical impact at a population level.
The laboratory has been established with the support of Siemens Healthineers Corporate Social Responsibility initiative, which also includes six M.Tech fellowships for women, aiming to enhance female representation in artificial intelligence. Dr. Vaanathi Sundaresan of IISc’s Department of CDS will lead the program. The focus of this collaborative laboratory will be to work closely with neurologists, radiologists and Siemens Healthineers and integrate the developed computational models into their regular clinical workflows.
Speaking on the partnership, Peter Schardt, Chief Technology Officer, Siemens Healthineers, said, “The collaboration with IISc solidifies our commitment to advancing precision medicine through AI using state-of-the-art, data-driven deep-learning techniques. Leveraging IISc’s academic excellence and our strong core in medical imaging, smart solutions developed through this collaboration will help us ultimately save lives through precise diagnoses and evidence-based treatments”.
Prof Govindan Rangarajan, Director, Indian Institute of Science, said, “This lab marks a crucial step forward in unlocking the potential of AI for precision medicine. Together, we are accelerating the future of healthcare for everyone. This collaboration is a powerful example of how industry and academia can come together to tackle complex challenges.”
The partnership between Siemens Healthineers and IISc is a milestone in artificial intelligence research in India, aiming to combat the world’s most threatening neurovascular diseases and pioneer breakthroughs in healthcare, it added.
